Systemic Redox Biomarkers in Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|16|1|46-70

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.1, 2015-01, pp. : 46-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Unbiased Search of Biomarkers in Neurodegenerative Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 5, 2016-04 ,pp. : 471-479

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 669-678

Bentham Science Publishers

Access to resources Recommend Favorite

Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-05 ,pp. : 380-387

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics-based discovery of biomarkers and therapeutic targets in neurodegenerative diseases: perspective of microglia and neuroinflammation

By Suk Kyoungho  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 237-247

Informa Healthcare

Access to resources Recommend Favorite

Cholinergic receptors and neurodegenerative diseases

By Gualtieri F.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite